Michael H. Wilson

Array ( [id] => 6926430 [patent_doc_number] => 20050239686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Methods and compositions for optimization of oxygen transport by cell-free systems' [patent_app_type] => utility [patent_app_number] => 11/034457 [patent_app_country] => US [patent_app_date] => 2005-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 39558 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20050239686.pdf [firstpage_image] =>[orig_patent_app_number] => 11034457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7180458 [patent_doc_number] => 20050124542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Crystallisation of a GLP-1 analogue' [patent_app_type] => utility [patent_app_number] => 11/018736 [patent_app_country] => US [patent_app_date] => 2004-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11379 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20050124542.pdf [firstpage_image] =>[orig_patent_app_number] => 11018736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7011351 [patent_doc_number] => 20050065067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Method and apparatus for preparing an acellular red blood cell substitute' [patent_app_type] => utility [patent_app_number] => 10/993228 [patent_app_country] => US [patent_app_date] => 2004-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6384 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20050065067.pdf [firstpage_image] =>[orig_patent_app_number] => 10993228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7142852 [patent_doc_number] => 20050118206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Surfactant-based gel as an injectable, sustained drug delivery vehicle' [patent_app_type] => utility [patent_app_number] => 10/985228 [patent_app_country] => US [patent_app_date] => 2004-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6363 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20050118206.pdf [firstpage_image] =>[orig_patent_app_number] => 10985228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7250259 [patent_doc_number] => 20050142150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Botulinum toxin formulations' [patent_app_type] => utility [patent_app_number] => 10/976690 [patent_app_country] => US [patent_app_date] => 2004-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2679 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20050142150.pdf [firstpage_image] =>[orig_patent_app_number] => 10976690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7605360 [patent_doc_number] => 07115569 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-03 [patent_title] => 'Exendins, exendin agonists, and methods for their use' [patent_app_type] => utility [patent_app_number] => 10/964887 [patent_app_country] => US [patent_app_date] => 2004-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 37738 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/115/07115569.pdf [firstpage_image] =>[orig_patent_app_number] => 10964887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6906142 [patent_doc_number] => 20050101537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Use of exendins and agonists thereof for lowering plasma lipid' [patent_app_type] => utility [patent_app_number] => 10/966337 [patent_app_country] => US [patent_app_date] => 2004-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 37163 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20050101537.pdf [firstpage_image] =>[orig_patent_app_number] => 10966337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4999789 [patent_doc_number] => 20070042423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Diagnostics and therapeutics for diseases associated with arginyl aminopeptidase rnpep-like (rnpep-like)' [patent_app_type] => utility [patent_app_number] => 10/573583 [patent_app_country] => US [patent_app_date] => 2004-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 36102 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20070042423.pdf [firstpage_image] =>[orig_patent_app_number] => 10573583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5253896 [patent_doc_number] => 20070135352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Use of lh for generating libido and reaching orgasm in female subjects' [patent_app_type] => utility [patent_app_number] => 10/575487 [patent_app_country] => US [patent_app_date] => 2004-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 364 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20070135352.pdf [firstpage_image] =>[orig_patent_app_number] => 10575487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5596808 [patent_doc_number] => 20060160726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Cyclic agonists and antagonists of C5a receptors and G protein-coupled receptors' [patent_app_type] => utility [patent_app_number] => 10/937852 [patent_app_country] => US [patent_app_date] => 2004-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11295 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160726.pdf [firstpage_image] =>[orig_patent_app_number] => 10937852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7011352 [patent_doc_number] => 20050065068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Methods and compositions for reducing serum phosphate levels' [patent_app_type] => utility [patent_app_number] => 10/918082 [patent_app_country] => US [patent_app_date] => 2004-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8179 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20050065068.pdf [firstpage_image] =>[orig_patent_app_number] => 10918082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7089623 [patent_doc_number] => 20050009736 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Methods and compositions for optimization of oxygen transport by cell-free systems' [patent_app_type] => utility [patent_app_number] => 10/917223 [patent_app_country] => US [patent_app_date] => 2004-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 39574 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009736.pdf [firstpage_image] =>[orig_patent_app_number] => 10917223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7122035 [patent_doc_number] => 20050013864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Cartilage/bone inducing materials for preparation' [patent_app_type] => utility [patent_app_number] => 10/885099 [patent_app_country] => US [patent_app_date] => 2004-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5090 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20050013864.pdf [firstpage_image] =>[orig_patent_app_number] => 10885099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 478031 [patent_doc_number] => 07223561 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-29 [patent_title] => 'Process of high purity albumin production' [patent_app_type] => utility [patent_app_number] => 10/873504 [patent_app_country] => US [patent_app_date] => 2004-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16504 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 272 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/223/07223561.pdf [firstpage_image] =>[orig_patent_app_number] => 10873504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 876477 [patent_doc_number] => 07358254 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-15 [patent_title] => 'Method for treating atherosclerosis employing an aP2 inhibitor and combination' [patent_app_type] => utility [patent_app_number] => 10/872721 [patent_app_country] => US [patent_app_date] => 2004-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8939 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/358/07358254.pdf [firstpage_image] =>[orig_patent_app_number] => 10872721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 876762 [patent_doc_number] => 07358332 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-15 [patent_title] => 'Bioactive peptides, uses thereof and process for the production of same' [patent_app_type] => utility [patent_app_number] => 10/848665 [patent_app_country] => US [patent_app_date] => 2004-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2892 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/358/07358332.pdf [firstpage_image] =>[orig_patent_app_number] => 10848665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 311080 [patent_doc_number] => 07528104 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-05 [patent_title] => 'Peptides that bind to the erythropoietin receptor' [patent_app_type] => utility [patent_app_number] => 10/555868 [patent_app_country] => US [patent_app_date] => 2004-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27146 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/528/07528104.pdf [firstpage_image] =>[orig_patent_app_number] => 10555868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7060551 [patent_doc_number] => 20050002911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Base material for regenerating an air sinus and regeneration method thereof' [patent_app_type] => utility [patent_app_number] => 10/841691 [patent_app_country] => US [patent_app_date] => 2004-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2953 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20050002911.pdf [firstpage_image] =>[orig_patent_app_number] => 10841691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7426383 [patent_doc_number] => 20040229802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Methods and compositions for treating ocular disease' [patent_app_type] => new [patent_app_number] => 10/823819 [patent_app_country] => US [patent_app_date] => 2004-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14466 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229802.pdf [firstpage_image] =>[orig_patent_app_number] => 10823819 [rel_patent_id] =>[rel_patent_doc_number] =>)